Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group's (MO) second-quarter 2022 results reflect increased earnings. Pricing remains an upside, though shipment volumes appear soft.

Altria (MO) Q2 Earnings Surpass Estimates, Revenues Drop Y/Y

Altria is a tough stock to own even though it pays a relatively safe 8% yield that comes with a positive outlook for growth.

Should High Yield Altria Be In Your Portfolio?

Source: Kristi Blokhin / Shutterstock.com Altria (NYSE: MO ) stock is sliding on Thursday after the company provided investors with an update on its Juul investment. According to Altria, the U.S. Food and Drug Administration's (FDA) investigation into Juul's smokeless tobacco products has caused its investment in the company to sharply drop.

Altria (MO) Stock Slips as Value of Juul Investment Dwindles

Altria (MO) delivered earnings and revenue surprises of 0.80% and 0.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Altria (MO) Q2 Earnings Top Estimates

Sometimes, where there's smoke, there are dividends.

You Can Count On This Ultra-High-Yield Dividend Stock

The Marlboro cigarette seller reported $6.54 billion in revenue, more than the $5.41 billion expected.

Altria's Earnings Beat Expectations. It Maintains Outlook.

Shares of Altria Group Inc. MO, -0.16% slipped 0.7% in premarket trading Thursday, after the smokeable products company reported second-quarter net profit that was less than half of last year's and revenue that fell a bit shy of forecasts. Net income dropped to $891 million or 49 cents a share, from $2.15 billion, or $1.16 a share, in the year ago period.

Altria stock falls as revenue slips below expectations, $1.2 billion loss recorded on JUUL investment

Marlboro maker Altria Group Inc on Thursday cut the value of its stake in Juul Labs Inc by about 72% to $450 million as the e-cigarette maker comes under intense regulatory scrutiny with the risk of a complete ban in the United States.

Altria cuts Juul stake value by 72%

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA REPORTS 2022 SECOND-QUARTER AND FIRST-HALF RESULTS; REAFFIRMS 2022 FULL-YEAR EARNINGS GUIDANCE

Altria Reports 2022 Second-Quarter and First-Half Results; Reaffirms 2022 Full-Year Earnings Guidance

Enbridge

Viatris

3 High-Yielding Dividend Stocks With Payout Ratios Over 100%

Altria (MO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for Altria (MO)

Altria Group's (MO) second-quarter 2022 results are likely to reflect gains from pricing and strength in oral tobacco products, whereas elevated costs are likely to have been a concern.

Altria Group (MO) Readies for Q2 Earnings: What to Expect?

Leggett & Platt

Universal Corp

"There is only one criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years."--Dogs of the Dow. 38 Dividend Kings and 5 Princes (next-in-line for kingship) (K&P) screened as of July 22, 2022, represented ten-of-eleven Morningstar Sectors. Broker targeted-top-ten net-gainers ranged 17.09%-39.59%, topped by MO & ABM.

Buy 3 Dividend Kings For July

British American Tobacco

Defensive dividend aristocrats like Altria and British American can make wonderful investments if you're worried about recessions, bear markets, or both. During the Great Recession, both grew earnings 30%, and they kept right on growing during the Pandemic, and analysts expect steady growth in a mild potential 2023 recession.

Altria And British American: 2 High-Yield Dividend Aristocrat Retirement Dream Buys

Curaleaf Holdings, Inc.

Innovative Industrial Properties

SNDL Inc.

Constellation Brands

Trulieve Cannabis Corp.

Tilray Brands

The cannabis industry can seem to catch a break. However, if you're risk tolerant, these are the seven best marijuana stocks to buy now.

7 Best Marijuana Stocks to Buy Now

AbbVie

Big Lots

Do you have these top high-yield dividend stocks on your watchlist right now?

3 High Yield Dividend Stocks To Watch Today

Black Hills

Clorox

Fresenius Medical Care

Medtronic

MDU Resources Group

National Fuel Gas

Novartis

Northwest Natural Gas

Philip Morris

Fears of a recession are mounting, with BAC and Deutsche Bank now forecasting a mild downturn in 2023. A recession could even begin by December 2022. Even without a recession Morgan Stanley is confident stocks have 10% lower to fall. If we get a mild recession, stocks could fall 25% more and in a severe recession, 35%.

11 High-Yield Dividend Aristocrats Perfect For The Coming Recession

Antero Midstream Partners

Devon Energy

New York Community Bancorp

Pioneer Natural Resources

AT&T

We got what we expected last week, as the consumer price index and producer price index came in again at levels not seen in 40 years.

7 Surprising Stocks That Pay Fat 5% and Higher Dividends Have Big Upside Potential

Amazon

Spirit Airlines

Should investors be watching these top consumer discretionary stocks in the stock market this week?

Top Stocks To Buy Now? 3 Consumer Discretionary Stocks To Watch

Apple

Chevron

Home Depot

Johnson & Johnson

Microsoft

Procter & Gamble

Walmart

Exxon Mobil

Take care in buying dividend stocks, which like General Electric can collapse when they make mistakes, just like other stocks. The post 10 Best Dividend Stocks of All Time appeared first on InvestorPlace.

10 Best Dividend Stocks of All Time

After a recent slide in the stock price, Altria now yields close to 9%. The dividend is covered by earnings, and the company has guided for earnings growth this year.

Is Altria A Good High-Yield Dividend Stock? It's A Trap

Lumen Technologies

These three stocks currently have the highest yields in the index.

3 Top Dividend Payers of the S&P 500

AGNC Investment

PennantPark Floating Rate Capital

These passive-income powerhouses, with yields ranging from 8.7% to 12.6%, can seriously pad investors' pocketbooks.

3 of the Safest Ultra-High-Yield Dividend Stocks on the Planet

Intel

JPMorgan Chase & Co

Pfizer

Target

These blue-chip stocks are trading at a discount due to near-term challenges. They can deliver healthy capital gains and dividend returns.

7 Blue-Chip Stocks Trading a Huge Discount Right Now

Vanguard Extended Duration Treasury ETF

Invesco Nasdaq 100 ETF

Schwab US Dividend Equity ETF

Isaac Newton was a genius who lost millions in the South Sea bubble, and my uncle is a genius who just lost $1 million in the crypto crash. But costly investment mistakes don't have to sink your rich retirement goals if you learn from your mistakes and trust the world's best dividend blue chips.

How I Built A $1 Million High-Yield Retirement Portfolio With 6 Dividend Blue Chips

News for Altria Stock (MO)